Shouldn’t the only narrative from the company fr
Post# of 148185
(Total Views: 683)
Posted On: 08/02/2020 9:47:22 AM
Shouldn’t the only narrative from the company from the beginning be . We believe our drug is better than Remdesivir.. Since Remdesivir is the SOC we have an easy hurdle medically and politically. No brained strategy . Yes the company has mentioned Remdesivir before publicly . But keep pounding it out there .
WE BELIEVE LERONLIMAB WILL OUT PREFORM THE SOC AND BE QUICKLY APPROVED FOR THE GOOD OF THE COUNTRY .
WE BELIEVE LERONLIMAB WILL OUT PREFORM THE SOC AND BE QUICKLY APPROVED FOR THE GOOD OF THE COUNTRY .
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼